Efficacy and Safety of Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 320 participants.

Also called NCT03037047

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 320 participants (planned count) (from the registry)
Sponsor
Green Valley Group of China (from the registry)
Registry
  • NCT NCT03037047
Other papers using this trial's data
  • A Prospective Randomized Multicenter Controlled Trial on Salvianolate for Treatment of Unstable Angina Pectoris in A Chinese Elderly Population Chinese journal of integrative medicine, 2019-10 DOI, PubMed 31782009

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03037047. Randomized; quadruple masking; primary purpose treatment. Start 2016-05-11 (actual); primary completion 2017-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Salvianolate Injection in Elderly Patients With Unstable Angina Pectoris
Condition
Unstable Angina
Intervention (Drug)
0.9% Sodium Chloride Injection
Intervention (Drug)
salvianolate injection
Lead sponsor
Green Valley Group of China (class: industry)

Record details

Record id
cardio:ct-nct03037047
Content hash
14c9e9097c5553b8663624fad5bca04e47b3f9c4271fa6865e0afb609272a0e4